← Oncology Approval Tracker

FDA DECISION ·

Cosela

trilaciclib · G1 Therapeutics

FDA approvalNew therapyChemotherapy-induced myelosuppression
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with extensive-stage small cell lung cancer, given before a platinum-etoposide-containing or topotecan-containing regimen to reduce chemotherapy-induced myelosuppression.

LAMPGEN ANALYSIS

Why it matters

The indication adds a strategy to reduce marrow toxicity during specified chemotherapy.

What research teams should watch

Build the pre-chemotherapy infusion into scheduling and track blood counts, transfusions and growth factor use.

PRIMARY RECORDS

Sources